References
1-Reddy VY, Exner DV, Doshi R, et al. Primary results on safety and efficacy from the LEADLESS II-Phase 2 worldwide clinical trial. J Am Coll Cardiol EP 2022; 8: 115-119.
2- Hauser RG, Gornick CC, Abdelhadi RH, Tang CT, Casey SA, Sengupta JD. Major adverse clinical events associated with implantation of a leadless intracardiac pacemaker. Heart Rhythm 2021; 18: 1132-1139.
3-Garg J, Shah K, Bhardwaj R, et al. Adverse events associated with Aveir VR leadless pacemaker: A Food and Drug Administration MAUDE database study. J Cardiovasc Electrophysiol 2023; ____________.